6.50Open7.42Pre Close4 Volume2.08K Open Interest70.00Strike Price2.66KTurnover49.78%IV0.51%PremiumDec 20, 2024Expiry Date6.41Intrinsic Value100Multiplier4DDays to Expiry0.39Extrinsic Value100Contract SizeAmericanOptions Type0.9623Delta0.0214Gamma11.76Leverage Ratio-0.0439Theta0.0068Rho11.31Eff Leverage0.0063Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet